Amin J - Search Results

1

Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.

Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Sierra Madero J, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Fisher M, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Arnaiz JA, Cooper D, Rockstroh JK, Mallon P, Emery S; Maraviroc Switch (MARCH) Study Group. Pett SL, et al. Among authors: amin j. Clin Infect Dis. 2016 Jul 1;63(1):122-32. doi: 10.1093/cid/ciw207. Epub 2016 Apr 5. Clin Infect Dis. 2016. PMID: 27048747 Free PMC article. Clinical Trial.

2

Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 study.

French M, Amin J, Roth N, Carr A, Law M, Emery S, Drummond F, Cooper D; OzCombo 2 investigators. French M, et al. Among authors: amin j. HIV Clin Trials. 2002 May-Jun;3(3):177-85. doi: 10.1310/9n21-1hg1-7n1q-jkw1. HIV Clin Trials. 2002. PMID: 12032876 Clinical Trial.

3

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.

Carr A, Workman C, Smith DE, Hoy J, Hudson J, Doong N, Martin A, Amin J, Freund J, Law M, Cooper DA; Mitochondrial Toxicity (MITOX) Study Group. Carr A, et al. Among authors: amin j. JAMA. 2002 Jul 10;288(2):207-15. doi: 10.1001/jama.288.2.207. JAMA. 2002. PMID: 12095385 Clinical Trial.

4

A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia.

Miller J, Brown D, Amin J, Kent-Hughes J, Law M, Kaldor J, Cooper DA, Carr A. Miller J, et al. Among authors: amin j. AIDS. 2002 Nov 8;16(16):2195-200. doi: 10.1097/00002030-200211080-00012. AIDS. 2002. PMID: 12409741 Clinical Trial.

5

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.

Martin A, Smith DE, Carr A, Ringland C, Amin J, Emery S, Hoy J, Workman C, Doong N, Freund J, Cooper DA; Mitochondrial Toxicity Study Group. Martin A, et al. Among authors: amin j. AIDS. 2004 Apr 30;18(7):1029-36. doi: 10.1097/00002030-200404300-00011. AIDS. 2004. PMID: 15096806 Clinical Trial.

6

Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy.

Winston A, Bloch M, Carr A, Amin J, Mallon PW, Ray J, Marriott D, Cooper DA, Emery S. Winston A, et al. Among authors: amin j. J Antimicrob Chemother. 2005 Aug;56(2):380-7. doi: 10.1093/jac/dki235. Epub 2005 Jul 4. J Antimicrob Chemother. 2005. PMID: 15996972

7

The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individuals.

Winston A, Hales G, Amin J, van Schaick E, Cooper DA, Emery S; CREST investigators. Winston A, et al. Among authors: amin j. AIDS. 2005 Sep 2;19(13):1393-9. doi: 10.1097/01.aids.0000181009.77632.36. AIDS. 2005. PMID: 16103770 Clinical Trial.

8

Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced HIV-positive individuals.

Winston A, Amin J, Hales G, Cooper DA, Emery S. Winston A, et al. Among authors: amin j. AIDS Res Hum Retroviruses. 2006 Apr;22(4):338-41. doi: 10.1089/aid.2006.22.338. AIDS Res Hum Retroviruses. 2006. PMID: 16623637

9

Enfuvirtide in HIV-1-infected individuals changing therapy to a nucleoside reverse transcriptase inhibitor sparing regimen: the ALLIANCE Study.

Dwyer DE, Workman C, Hales G, Amin J, Cooper D, Miller J; Alliance Study Group. Dwyer DE, et al. Among authors: amin j. Antivir Ther. 2006;11(4):409-19. Antivir Ther. 2006. PMID: 16856614 Clinical Trial.

10

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.

Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, Petcharapirat P, Marks P, Sasadeusz J, Cooper DA, Bowden S, Locarnini S, Ruxrungtham K, Dore GJ. Matthews GV, et al. Among authors: amin j. Hepatology. 2008 Oct;48(4):1062-9. doi: 10.1002/hep.22462. Hepatology. 2008. PMID: 18697216 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

496 results

Search Page